Three Epidural Steroid Techniques

A 32-year-old man presents to your clinic with 6-week onset of left-sided low back pain radiating down his left posterolateral leg to the top of his left foot. His symptoms include painful shooting electrical sensations, numbness and tingling, and mild weakness in raising his foot. His deep tendon reflexes are normal and he has a positive slump sit test result on the left lower extremity. His primary care physician prescribed gabapentin and a course of oral steroids (methylprednisolone), with minimal benefit.
Source: PM and R - Category: Rehabilitation Authors: Tags: Point/Counterpoint Source Type: research

Related Links:

Objective The aim of the study was to investigate the effects of the inclusion of neural mobilization into a motor control exercise program on pain, related disability, neuropathic symptoms, straight leg raise, and pressure pain threshold in lumbar radiculopathy. Design This is a randomized clinical trial. Methods Individuals with low back pain, with confirmed disc herniation, and lumbar radiculopathy were randomly assigned to receive eight sessions of either neurodynamic mobilization plus motor control exercises (n = 16) or motor control exercises alone (n = 16). Outcomes included pain, disability, neuropathic sym...
Source: American Journal of Physical Medicine and Rehabilitation - Category: Rehabilitation Tags: Original Research Articles Source Type: research
Conclusions Stabilization exercises could improve the voluntary activity of transverse abdominal muscle of mothers of children with cerebral palsy.
Source: American Journal of Physical Medicine and Rehabilitation - Category: Rehabilitation Tags: Original Research Articles Source Type: research
AbstractPurposeTo define and analyze the learning curve of percutaneous endoscopic transforaminal decompression (PETD) for lumbar spinal stenosis (LSS).MethodsFrom July 2015 to September 2016, 78 patients underwent PETD; one of whom was converted to open surgery, two were lost, and 75 were included in this study. Clinical results were assessed by using the Oswestry Disability Index (ODI) and visual analog scale (VAS). The learning curve was assessed by a logarithmic curve-fitting regression analysis. Of these 75 patients, 35 were defined as the “early” group, and 40 were defined as the “late” group ...
Source: International Orthopaedics - Category: Orthopaedics Source Type: research
No abstract available
Source: The Back Letter - Category: Orthopaedics Tags: Articles Source Type: research
(Reuters Health) - Common myths about low back pain could lead to more pain, ineffective care and unwarranted anxiety, researchers say.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Most cases of low back pain (LBP) are regarded as non-specific and current studies indicate that for many this is a chronic recurrent condition, in which people experience episodes of pain with symptom-free pe...
Source: Chiropractic and Osteopathy - Category: Complementary Medicine Authors: Tags: Study protocol Source Type: research
Conclusions: Many patients who develop new LBP receive guideline nonconcordant care such as early advanced imaging and opioids before other modalities like PT and prescription NSAIDs.
Source: Medical Care - Category: Health Management Tags: Original Articles Source Type: research
ConclusionBoth TA and AS have no significant adverse effects on pregnancy if diagnosed and timely treated properly. When they occur concomitantly, more attention and care is needed to prevent complications.
Source: The Egyptian Rheumatologist - Category: Rheumatology Source Type: research
Cartilage should be soft and firm, protecting the spine vertebrae. But a study on mice at Johns Hopkins University School of Medicine, Baltimore, found it had hardened and looked like Swiss cheese.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
A rejection of its experimental pain drug Tuesday forced Nektar Therapeutics Inc. to dump the program. In a rare indisputable rejection, two Food and Drug Administration advisory committees voted 27-0 to recommend that the FDA not approve the San Francisco company's oxycodegol, a slow-acting opioid aimed at chronic lower back pain. The FDA isn't required to live by the advisory committees' recomme ndation, but six hours later Nektar (NASDAQ: NKTR) said it would withdraw its approval request and…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news
More News: Back Pain | Gabapentin | Low Back Pain | Methylprednisolone | Neurontin | Pain | Primary Care